230 per tablet about 4600 rs per 20 tablet bottle'

The treatability of liver cancer depends on various factors, including the stage at which the cancer is diagnosed, the overall health of the patient, and the available treatment options. Treatment approaches for liver cancer can include surgery, liver transplantation, ablation therapies, radiation therapy, and systemic therapies.

Surgery:

Surgical options for liver cancer may include the removal of the tumor or, in some cases, a portion of the liver (partial hepatectomy). However, surgery is often considered when the cancer is in its early stages and has not spread extensively.

Liver Transplantation:

Liver transplantation may be an option for some patients with small tumors or early-stage liver cancer. This involves replacing the diseased liver with a healthy liver from a donor.

Ablation Therapies:

Ablation therapies, such as radiofrequency ablation (RFA) or microwave ablation, use heat to destroy cancer cells. These approaches are suitable for small tumors and may be considered in patients who are not candidates for surgery.

Radiation Therapy:

External beam radiation therapy or internal radiation (brachytherapy) may be used to target and destroy cancer cells. Radiation therapy is often employed to manage symptoms and slow the progression of the disease.

Systemic Therapies:

Systemic therapies include chemotherapy, targeted therapy, and immunotherapy. These treatments are administered to the entire body and are often used for advanced or metastatic liver cancer.

Chemoembolization:

Transarterial chemoembolization (TACE) involves injecting chemotherapy drugs directly into the blood vessels supplying the tumor, followed by blocking the blood supply to the tumor. This is commonly used for intermediate-stage liver cancer.

Targeted Therapies:

Targeted therapies aim to inhibit specific molecules involved in cancer growth. Sorafenib and lenvatinib are examples of targeted therapies approved for the treatment of advanced liver cancer.

A diagnosis of kidney cancer is terrifying, particularly because of the high mortality rate. However, recent medical advances have substantially reduced the mortality rate.

For kidney cancer that is caught early, laparoscopic surgery remains the primary treatment option. In this procedure, small incisions are made in the abdomen and the tumor is removed through these incisions. If the cancer has begun to spread, or metastasize, then traditional surgery is recommended for the most thorough removal of the damaged cells from all organs. Statistically, longevity increases for those who have surgery over those who do not.

Another treatment option is immunotherapy, which uses medications to increase the body's immune response to the cancerous cells. Although this option is effective in less than one-fourth of patients, it has caused long-term remission in about half of those who respond to it. Studies have found the survival rate to be more than 20 years in some cases and research is being conducted to determine the type of patient who is most apt to respond to immunotherapy.

Targeted treatments have also shown to be efficacious in treating metastasized kidney cancer, particularly when combined with immunotherapy treatments. Targeted treatments are less damaging to surrounding cells and fewer side effects have been reported.

The FDA has approved three drugs for use in treating metastasized cancer: Torisel, generic name temsirolimus, Sutent, generic name sunitinib, and Nexavar, generic name sorafenib.

The most effective drug for treating kidney cancer, Sutent, is usually prescribed as the first defense for kidney cancer that has metastasized. However, the side effects are more severe and can include high blood pressure; therefore, not all kidney cancer patients can tolerate Sutent. As well, the drug Torisel has significantly greater side effects that some patients cannot tolerate, although it is very effective at treating metastasized kidney cancer.

Nexavar has fewer and milder side effects than some of the others and has effectively shrunk tumors when other medications failed. Primarily, Nexavar works by inhibiting the blood supply to the existing cancer cells so they cannot produce new cells.

Many new treatments are currently in the clinical trial stage. For those who have been diagnosed with kidney cancer, enrolling in a clinical trial may be the answer if none of the current treatments seem satisfactory.

The treatment options for thyroid cancer can vary depending on the type and stage of the cancer, as well as the individual's overall health and preferences. The main treatments for thyroid cancer include:

Surgery: Surgery is the primary treatment for most thyroid cancers. The extent of surgery depends on the size and location of the tumor. Options include:

Thyroidectomy: This is the removal of all or part of the thyroid gland. It can be a lobectomy (removal of one lobe) or a total thyroidectomy (removal of the entire gland).

Lymph node removal: If cancer has spread to nearby lymph nodes, they may also be removed during surgery.

Radioactive Iodine (RAI) Therapy: After surgery, RAI therapy may be used to destroy any remaining thyroid tissue and cancer cells. Thyroid cells absorb iodine, so RAI is effective in targeting any remnants of thyroid tissue. RAI therapy is more commonly used for well-differentiated thyroid cancers (papillary and follicular types).

External Beam Radiation Therapy: This treatment involves using high-energy X-rays to target and destroy cancer cells. It is typically used if cancer has spread beyond the thyroid or if RAI therapy is not effective.

Targeted Drug Therapy: In cases of advanced or recurrent thyroid cancer that doesn't respond to other treatments, targeted therapies like tyrosine kinase inhibitors (e.g., sorafenib, lenvatinib) may be used. These drugs can inhibit the growth of cancer cells by targeting specific signaling pathways.

Chemotherapy: Chemotherapy is not commonly used for most types of thyroid cancer, but it might be considered for more aggressive and less common types that do not respond to other treatments.

Thyroid Hormone Replacement Therapy: After thyroidectomy, patients will need to take synthetic thyroid hormone medications (such as levothyroxine) to replace the hormones normally produced by the thyroid. This also helps suppress the production of thyroid-stimulating hormone (TSH), which can potentially stimulate any remaining thyroid cancer cells.

Watchful Waiting: For some low-risk papillary microcarcinomas, especially in elderly patients, watchful waiting (active surveillance) might be considered. This involves monitoring the cancer without immediate treatment.

The choice of treatment depends on factors such as the type of thyroid cancer, its stage, the patient's age, overall health, and preferences. It's important for individuals diagnosed with thyroid cancer to work closely with a multidisciplinary team of doctors, including endocrinologists, surgeons, oncologists, and radiation therapists, to develop a personalized treatment plan that offers the best possible outcome.